Polem: Avelumab Plus Fluoropyrimidine-Based Chemotherapy As Adjuvant Treatment For Stage Iii Dmmr Or Pole Exonuclease Domain Mutant Colon Cancer A Phase Iii Randomized Study.

JOURNAL OF CLINICAL ONCOLOGY(2019)

引用 15|浏览31
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要